Skip to content

Tradersville

Tradersville
Menu
  • Home
  • Latest News
  • Trade Ideas
  • About Us
  • Contact Us
Latest News 
November 18, 2026November 18, 2026

Innate Pharma stock tumbles after phase 1 trial data

Posted By: techrossm
view original post

Innate Pharma (NASDAQ:IPHA) shares fell 17% Wednesday following the release of phase 1 data for its investigational Nectin-4-targeting antibody-drug conjugate IPH4502.

Post navigation

Anthropic stock options could begin trading Monday — Channel NewsAsia
Stock market today: Dow drops on hawkish Fed stance; SEC probe hits Nvidia (live coverage)
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us and our affiliates. Opt-out any time, we hate spam!

Sponsored content
Copyright © 2026 - Tradersville
Terms of Use | Privacy | Disclosure | Do Not Sell My Info - CA Resident Only